Short-term outcomes of CyberKnife therapy for advanced high-risk tumors: A report of 160 cases

Wang,Yi-Shan; Wang,Yuan-Yuan; Jiang,Peng; Ma,Jian-Jun; Qu,Zhen; Wang,Xi-Lin; Li,Jun-Ti; Jia,Xi-Feng

doi:10.3892/etm.2012.451

Short-term outcomes of CyberKnife therapy for advanced high-risk tumors: A report of 160 cases

Authors:
- Yi-Shan Wang
- Yuan-Yuan Wang
- Peng Jiang
- Jian-Jun Ma
- Zhen Qu
- Xi-Lin Wang
- Jun-Ti Li
- Xi-Feng Jia
View Affiliations

Affiliations: Center for Tumor Treatment, The People's Liberation Army 107th Hospital, Shandong 264002, P.R. China
Published online on: January 12, 2012 https://doi.org/10.3892/etm.2012.451
Pages: 725-727

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The objective of the present study was to evaluate short-term outcomes of CyberKnife therapy in patients with advanced high-risk tumors. A total of 201 target areas from 341 advanced high-risk tumor lesions in 160 patients were treated with CyberKnife. A prescribed dose of 18-60 Gy to the gross tumor volume was delivered in 1-6 fractions to complete the entire treatment in 1 week. Radiographic studies and clinical examinations were performed at 1- to 3-month follow‑up intervals, and the results were compared to outcomes of 160 similar advanced high-risk tumor patients who were treated by conformal radiotherapy (CRT). After CyberKnife therapy, the short-term improvement in the quality of life was significant according to radiographic study, radioimmunoassay and ZPS scores of these patients. The total rates of objective efficacy and alleviation of ascities were as high as 66.88 and 67.90%. The short-term outcomes in our series of patients with advanced high-risk tumors treated with CyberKnife appeared to be better compared to conventional CRT. CyberKnife may be an option for patients with incurable advanced high-risk tumors, although further studies of the long-term outcomes are required to confirm the validity.

View Figures

View References

1.	Chang BK and Timmerman RD: Stereotactic body radiation therapy: a comprehensive review. Am J Clin Oncol. 30:637–644. 2007. View Article : Google Scholar : PubMed/NCBI
2.	Shirato H, Shimizu S, Kitamura K and Onimaru R: Organ motion in image-guided radiotherapy: lessons from real-time tumor tracking radiotherapy. Int J Clin Oncol. 12:8–16. 2007. View Article : Google Scholar : PubMed/NCBI
3.	Dewas S, Dewas-Vautravers C, Servent V, et al: Results and special considerations when treating elderly patients with CyberKnife: a review of 345 cases. Crit Rev Oncol Hematol. 76:1–7. 2010.PubMed/NCBI
4.	Brown WT, Wu X, Wen BC, et al: Early results of CyberKnife image-guided robotic stereotactic radiosurgery for treatment of lung tumors. Comput Aided Surg. 12:253–261. 2007. View Article : Google Scholar : PubMed/NCBI
5.	Bucholz RD, Laycock KA and Cuff LE: CyberKnife stereo-tactic radiosurgery for intracranial neoplasms, with a focus on malignant tumors. Technol Cancer Res Treat. 9:541–550. 2010. View Article : Google Scholar : PubMed/NCBI
6.	Nagata Y, Matsuo Y, Takayama K, et al: Current status of stereo-tactic body radiotherapy for lung cancer. Int J Clin Oncol. 12:3–7. 2007. View Article : Google Scholar
7.	Yamazaki H, Shiomi H, Tsubokura T, et al: Quantitative assessment of inter-observer variability in target volume delineation on stereotactic radiotherapy treatment for pituitary adenoma and meningioma optic tract. Radiat Oncol. 6:102011.
8.	Hasney CP, Swanton RG and Friendlander PL: CyberKnife stereotactic radiosurgery for recurrent squamous cell carcinoma of the head and neck following salvage surgery with close or positive margins. Laryngoscope. 4:1522010. View Article : Google Scholar : PubMed/NCBI
9.	Oermann EK, Slack RS, Hanscom HN, et al: A pilot study of intensity modulated radiation therapy with hypofractionated stereotactic body radiation therapy (SBRT) boost in the treatment of intermediate to high-risk prostate cancer. Technol Cancer Res Treat. 9:453–462. 2010. View Article : Google Scholar : PubMed/NCBI
10.	Unger F, Dominikus K and Haselsberger K: Stereotactic radiosurgery and fractionated stereotactic radiotherapy of acoustic neuromas. HNO. 59:31–37. 2011.(In German).
11.	Alongi F and Di Muzio N: Image-guided radiation therapy: A new era for the radiation oncologist? Int J Clin Oncol. 14:568–569. 2009. View Article : Google Scholar : PubMed/NCBI
12.	Schweikard A, Shiomi H and Adler J: Respiration tracking in radiosurgery. Med Phys. 31:2738–2741. 2004. View Article : Google Scholar
13.	Jereczed-Fossa BA, Beltramo G, Fariselli L, et al: Robotic image-guided stereotactic radiotherapy, for isolated recurrent primary, lymph node or metastatic prostate cancer. Int J Radiat Oncol Biol Phys. 79:1–9. 2011.PubMed/NCBI
14.	Reichner C, Collins B, Gagnon G, et al: The placement of gold fiducials for cyberknife stereotactic radiosurgery using a modified transbronchial needle aspiration technique. J Bronchol. 12:193–195. 2005. View Article : Google Scholar
15.	Collins BT, Erickson K, Reichner CA, et al: Radical stereotactic radiosurgery with real-time tumor motion tracking in the treatment of small peripheral lung tumors. Radiat Oncol. 2:392007. View Article : Google Scholar : PubMed/NCBI
16.	Hashizume M: MRI-guided laparoscopic and robotic surgery for malignancies. Int J Clin Oncol. 12:94–98. 2007. View Article : Google Scholar : PubMed/NCBI
17.	Roh KW, Jang JS, Kim MS, et al: Fractionated stereotactic radiotherapy as reirradiation for locally recurrent head and neck cancer. Int J Radiat Onc Biol Phys. 74:1348–1355. 2009. View Article : Google Scholar
18.	King CR, Brooks JD, Gill H, et al: Stereotactic body radiotherapy for localized prostate cancer: interim results of a prospective phase II clinical trial. Int J Radiat Oncol Biol Phys. 73:1043–1048. 2009. View Article : Google Scholar : PubMed/NCBI
19.	Brown WT, Fayad F, Hevezi J, et al: Individualized higher dose of 70–75 Gy using five-fraction robotic stereotactic radiotherapy for non-small-cell lung cancer: a feasibility study. Comput Aided Surg. 16:1–10. 2011.
20.	Vavassori A, Jereczek-Fossa BA, Beltramo G, et al: Image-guided robotic radiosurgery as salvage therapy for locally recurrent prostate cancer after external beam irradiation: retrospective feasibility study on six cases. Tumori. 96:71–75. 2010.
21.	Yoshioka Y: Current status and perspectives of brachytherapy for prostate cancer. Int J Clin Oncol. 14:31–36. 2009. View Article : Google Scholar : PubMed/NCBI
22.	Thariat J, Li G, Angellier G, et al: Current indications and ongoing clinical trials with CyberKnife stereotactic radiotherapy in France in 2009. Bull Cancer. 96:853–864. 2009.PubMed/NCBI
23.	Xie Y, Djajaputra D, King CR, et al: Intrafractional motion of the prostate during hypofractionated radiotherapy. Int J Radiat Oncol Biol Phys. 72:236–246. 2008. View Article : Google Scholar : PubMed/NCBI
24.	Fowler JF, Welsh JS, Howard SP, et al: Loss of biological effect in prolonged fraction delivery. Int J Radiat Oncol Biol Phys. 159:242–249. 2004. View Article : Google Scholar : PubMed/NCBI
25.	Fuller DB, Naitoh J, Lee C, et al: Virtual HDR CyberKnife treatment for localized prostatic carcinoma: dosimetry comparison with HDR brachytherapy and preliminary clinical observations. Int J Radiat Oncol Biol Phys. 70:1588–1597. 2008. View Article : Google Scholar
26.	Naito S: Recent developments and perspectives of image-guided precision surgery for malignant. Int J Clin Oncol. 12:69–70. 2007. View Article : Google Scholar
27.	Hara W, Loo BW, Goffinet DR, et al: Excellent local control with stereotactic radiotherapy boost after external beam radiotherapy in patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 71:393–400. 2008. View Article : Google Scholar : PubMed/NCBI